Indian Journal of Urology Users online:2257  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

Randomized double-blind controlled clinical trial of serenoa repens versus placebo in the management of patients with symptomatic grade I to grade II benign prostatic hyperplasia (BPH).

Mohanty N K, Jha R J, Dutt C

Year : 1999| Volume: 15| Issue : 1 | Page no: 26-31

   This article has been cited by
1 Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): An updated Cochrane systematic review
MacDonald, R. and Tacklind, J.W. and Rutks, I. and Wilt, T.J.
BJU International. 2012; 109(12): 1756-1761
[Pubmed]  [Google Scholar]
2 Evidence-based systematic review of Saw palmetto by the Natural Standard Research Collaboration
Ulbricht, C. and Basch, E. and Bent, S. and Boon, H. and Corrado, M. and Foppa, I. and Hashmi, S. and Hammerness, P. and Kingsbury, E. and Smith, M. and Szapary, P. and Vora, M. and Weissner, W.
Journal of the Society for Integrative Oncology. 2006; 4(4): 170-186
[Pubmed]  [Google Scholar]


Read this article